Metabolomics Workbench : NIH Data Repository

Clustering data with heatmap algorithm for (Study ST000381)

This analysis uses the 'heatmap.2' function of gplots package in the R statistics environment

The rows are scaled to have mean=0 and standard deviation=1

Factors:

F1	Cohort:CSMC \| Treatment:ICPBS Urine-IC12 \| SubCondition:SEVERE
F2	Cohort:CSMC \| Treatment:ICPBS Urine-IC14 \| SubCondition:SEVERE
F3	Cohort:CSMC \| Treatment:ICPBS Urine-IC19 \| SubCondition:SEVERE
F4	Cohort:CSMC \| Treatment:ICPBS Urine-IC20 \| SubCondition:SEVERE
F5	Cohort:CSMC \| Treatment:ICPBS Urine-IC21 \| SubCondition:SEVERE
F6	Cohort:CSMC \| Treatment:ICPBS Urine-IC22 \| SubCondition:SEVERE
F7	Cohort:CSMC \| Treatment:ICPBS Urine-IC30 \| SubCondition:SEVERE
F8	Cohort:CSMC \| Treatment:ICPBS Urine-IC31 \| SubCondition:SEVERE
F9	Cohort:CSMC \| Treatment:ICPBS Urine-IC32 \| SubCondition:SEVERE
F10	Cohort:CSMC \| Treatment:ICPBS Urine-IC48 \| SubCondition:SEVERE
F11	Cohort:CSMC \| Treatment:ICPBS Urine-IC52 \| SubCondition:SEVERE
F12	Cohort:CSMC \| Treatment:ICPBS Urine-IC53 \| SubCondition:SEVERE
F13	Cohort:CSMC \| Treatment:ICPBS Urine-IC5 \| SubCondition:SEVERE
F14	Cohort:CSMC \| Treatment:ICPBS Urine-IC9 \| SubCondition:SEVERE
F15	Cohort:CSMC \| Treatment:Matched control-C10 \| SubCondition:n/a
F16	Cohort:CSMC \| Treatment:Matched control-C13 \| SubCondition:n/a
F17	Cohort:CSMC \| Treatment:Matched control-C15 \| SubCondition:n/a
F18	Cohort:CSMC \| Treatment:Matched control-C16 \| SubCondition:n/a
F19	Cohort:CSMC \| Treatment:Matched control-C17 \| SubCondition:n/a
F20	Cohort:CSMC \| Treatment:Matched control-C18 \| SubCondition:n/a
F21	Cohort:CSMC \| Treatment:Matched control-C26 \| SubCondition:n/a
F22	Cohort:CSMC \| Treatment:Matched control-C27 \| SubCondition:n/a
F23	Cohort:CSMC \| Treatment:Matched control-C28 \| SubCondition:n/a
F24	Cohort:CSMC \| Treatment:Matched control-C33 \| SubCondition:n/a
F25	Cohort:CSMC \| Treatment:Matched control-C40 \| SubCondition:n/a
F26	Cohort:CSMC \| Treatment:Matched control-C45 \| SubCondition:n/a
F27	Cohort:CSMC \| Treatment:Matched control-C49 \| SubCondition:n/a
F28	Cohort:CSMC \| Treatment:Matched control-C50 \| SubCondition:n/a
F29	Cohort:CSMC \| Treatment:Matched control-C51 \| SubCondition:n/a
F30	Cohort:INHA \| Treatment:ICPBS Urine-IC 10 \| SubCondition:SEVERE
F31	Cohort:INHA \| Treatment:ICPBS Urine-IC 11 \| SubCondition:MODEST
F32	Cohort:INHA \| Treatment:ICPBS Urine-IC 12 \| SubCondition:MODEST
F33	Cohort:INHA \| Treatment:ICPBS Urine-IC 13 \| SubCondition:MODEST
F34	Cohort:INHA \| Treatment:ICPBS Urine-IC 14 \| SubCondition:SEVERE
F35	Cohort:INHA \| Treatment:ICPBS Urine-IC 15 \| SubCondition:SEVERE
F36	Cohort:INHA \| Treatment:ICPBS Urine-IC 16 \| SubCondition:SEVERE
F37	Cohort:INHA \| Treatment:ICPBS Urine-IC 17 \| SubCondition:MODEST
F38	Cohort:INHA \| Treatment:ICPBS Urine-IC 18 \| SubCondition:MODEST
F39	Cohort:INHA \| Treatment:ICPBS Urine-IC 19 \| SubCondition:SEVERE
F40	Cohort:INHA \| Treatment:ICPBS Urine-IC 1 \| SubCondition:SEVERE
F41	Cohort:INHA \| Treatment:ICPBS Urine-IC 20 \| SubCondition:SEVERE
F42	Cohort:INHA \| Treatment:ICPBS Urine-IC 21 \| SubCondition:MODEST
F43	Cohort:INHA \| Treatment:ICPBS Urine-IC 22 \| SubCondition:INTERMEDIATE
F44	Cohort:INHA \| Treatment:ICPBS Urine-IC 24 \| SubCondition:MODEST
F45	Cohort:INHA \| Treatment:ICPBS Urine-IC 25 \| SubCondition:MODEST
F46	Cohort:INHA \| Treatment:ICPBS Urine-IC 26 \| SubCondition:MODEST
F47	Cohort:INHA \| Treatment:ICPBS Urine-IC 27 \| SubCondition:INTERMEDIATE
F48	Cohort:INHA \| Treatment:ICPBS Urine-IC 28 \| SubCondition:MODEST
F49	Cohort:INHA \| Treatment:ICPBS Urine-IC 29 \| SubCondition:SEVERE
F50	Cohort:INHA \| Treatment:ICPBS Urine-IC 2 \| SubCondition:SEVERE
F51	Cohort:INHA \| Treatment:ICPBS Urine-IC 30 \| SubCondition:INTERMEDIATE
F52	Cohort:INHA \| Treatment:ICPBS Urine-IC 31 \| SubCondition:SEVERE
F53	Cohort:INHA \| Treatment:ICPBS Urine-IC 32 \| SubCondition:MODEST
F54	Cohort:INHA \| Treatment:ICPBS Urine-IC 33 \| SubCondition:MODEST
F55	Cohort:INHA \| Treatment:ICPBS Urine-IC 34 \| SubCondition:SEVERE
F56	Cohort:INHA \| Treatment:ICPBS Urine-IC 35 \| SubCondition:SEVERE
F57	Cohort:INHA \| Treatment:ICPBS Urine-IC 36 \| SubCondition:SEVERE
F58	Cohort:INHA \| Treatment:ICPBS Urine-IC 37 \| SubCondition:MODEST
F59	Cohort:INHA \| Treatment:ICPBS Urine-IC 38 \| SubCondition:INTERMEDIATE
F60	Cohort:INHA \| Treatment:ICPBS Urine-IC 39 \| SubCondition:SEVERE
F61	Cohort:INHA \| Treatment:ICPBS Urine-IC 3 \| SubCondition:SEVERE
F62	Cohort:INHA \| Treatment:ICPBS Urine-IC 40 \| SubCondition:INTERMEDIATE
F63	Cohort:INHA \| Treatment:ICPBS Urine-IC 41 \| SubCondition:MODEST
F64	Cohort:INHA \| Treatment:ICPBS Urine-IC 42 \| SubCondition:INTERMEDIATE
F65	Cohort:INHA \| Treatment:ICPBS Urine-IC 43 \| SubCondition:INTERMEDIATE
F66	Cohort:INHA \| Treatment:ICPBS Urine-IC 4 \| SubCondition:INTERMEDIATE
F67	Cohort:INHA \| Treatment:ICPBS Urine-IC 5 \| SubCondition:MODEST
F68	Cohort:INHA \| Treatment:ICPBS Urine-IC 6 \| SubCondition:SEVERE
F69	Cohort:INHA \| Treatment:ICPBS Urine-IC 7 \| SubCondition:MODEST
F70	Cohort:INHA \| Treatment:ICPBS Urine-IC 8 \| SubCondition:INTERMEDIATE
F71	Cohort:INHA \| Treatment:ICPBS Urine-IC 9 \| SubCondition:MODEST
F72	Cohort:INHA \| Treatment:Matched control-C 10 \| SubCondition:n/a
F73	Cohort:INHA \| Treatment:Matched control-C 11 \| SubCondition:n/a
F74	Cohort:INHA \| Treatment:Matched control-C 12 \| SubCondition:n/a
F75	Cohort:INHA \| Treatment:Matched control-C 13 \| SubCondition:n/a
F76	Cohort:INHA \| Treatment:Matched control-C 14 \| SubCondition:n/a
F77	Cohort:INHA \| Treatment:Matched control-C 15 \| SubCondition:n/a
F78	Cohort:INHA \| Treatment:Matched control-C 16 \| SubCondition:n/a
F79	Cohort:INHA \| Treatment:Matched control-C 17 \| SubCondition:n/a
F80	Cohort:INHA \| Treatment:Matched control-C 18 \| SubCondition:n/a
F81	Cohort:INHA \| Treatment:Matched control-C 19 \| SubCondition:n/a
F82	Cohort:INHA \| Treatment:Matched control-C 1 \| SubCondition:n/a
F83	Cohort:INHA \| Treatment:Matched control-C 20 \| SubCondition:n/a
F84	Cohort:INHA \| Treatment:Matched control-C 21 \| SubCondition:n/a
F85	Cohort:INHA \| Treatment:Matched control-C 2 \| SubCondition:n/a
F86	Cohort:INHA \| Treatment:Matched control-C 3 \| SubCondition:n/a
F87	Cohort:INHA \| Treatment:Matched control-C 4 \| SubCondition:n/a
F88	Cohort:INHA \| Treatment:Matched control-C 5 \| SubCondition:n/a
F89	Cohort:INHA \| Treatment:Matched control-C 6 \| SubCondition:n/a
F90	Cohort:INHA \| Treatment:Matched control-C 7 \| SubCondition:n/a
F91	Cohort:INHA \| Treatment:Matched control-C 8 \| SubCondition:n/a
F92	Cohort:INHA \| Treatment:Matched control-C 9 \| SubCondition:n/a

Data matrix